1 Selected P. falciparum specific immune responses are maintained in AIDS adults in Burkina Faso

2 Frequent Recovery of HIV-1 From Genital Herpes Simplex Virus Lesions in HIV-1–Infected Men

3 The role of HSV in the transmission and progression of HIV

4 Incidence of malaria and efficacy of oral quinine in patients recently infected with human immunodeficiency virus in Kinshasa, Zaire

5 The effect of anthelmintic treatment during pregnancy on HIV plasma viral load: results from a randomized, double-blind, placebo-controlled trial in Uganda

6 Relation between stage of disease and neurobehavioral measures in children with symptomatic HIV disease

7 Glycosylation of the HIV-1 Env V1V2 loop to form a native-like structure may not be essential with a nanoparticle vaccine.

8 Novel 1,5-Diphenylpyrazole Nonnucleoside HIV-1 Reverse Transcriptase Inhibitors with Enhanced Activity versus the Delavirdine-Resistant P236L Mutant: Lead Identification and SAR of 3- and 4-Substituted Derivatives

9 Molecular Docking Study of Four Chromene Derivatives as Novel HIV-1 Integrase Inhibitors

10 Lipid profile improvement in virologically suppressed HIV-1-infected patients switched to dolutegravir/abacavir/lamivudine: data from the SCOLTA project

11 High rate of HIV-1 drug resistance in treatment failure patients in Taiwan, 2009–2014

12 Extended use of raltegravir in the treatment of HIV-1 infection: optimizing therapy

13 Lipid profile improvement in virologically suppressed HIV-1-infected patients switched to dolutegravir/abacavir/lamivudine: data from the SCOLTA project

14 High rate of HIV-1 drug resistance in treatment failure patients in Taiwan, 2009–2014

15 Extended use of raltegravir in the treatment of HIV-1 infection: optimizing therapy

16 Investigating the distribution of HIV-1 Tat lengths present in the Drexel Medicine CARES cohort.

17 Structural and binding insights into HIV-1 protease and P2-ligand interactions through molecular dynamics simulations, binding free energy and principal component analysis.

18 The global spread of HIV-1 subtype B epidemic.

19 Increased Plasma Levels of the TH2 chemokine CCL18 associated with low CD4+ T cell counts in HIV-1-infected Patients with a Suppressed Viral Load

20 Feasibility of using dried blood spots for HIV viral load testing among HIV-infected individuals in Thailand using QIAGEN QIAsymphony-artus HIV-1 platform

21 Control of the HIV-1 Load Varies by Viral Subtype in a Large Cohort of African Adults with Incident HIV-1 Infection

22 Analytical treatment interruption in chronic HIV-1 infection: Time and magnitude of viral rebound in adults with 10 years of undetectable viral load and low HIV-DNA (APACHE study)

23 Inhibition of HIV-1 envelope-dependent membrane fusion by serum antilymphocyte autoantibodies is associated with low plasma viral load

24 AAV-Mediated Expression of Broadly Neutralizing and Vaccine-like Antibodies Targeting the HIV-1 Envelope V2 Region.

25 Novel Conserved-region T-cell Mosaic Vaccine With High Global HIV-1 Coverage Is Recognized by Protective Responses in Untreated Infection.

26 Characterization of T-cell responses to conserved regions of the HIV-1 proteome in BALB/c mice.

27 A short-term assessment of nascent HIV-1 transmission clusters among newly diagnosed individuals using envelope sequence-based phylogenetic analyses.

28 Ledipasvir/Sofosbuvir for 8 Weeks to Treat Acute Hepatitis C Virus Infections in Men With Human Immunodeficiency Virus Infections: Sofosbuvir-Containing Regimens Without Interferon for Treatment of Acute HCV in HIV-1 Infected Individuals.

29 Methamphetamine functions as a novel CD4<sup>+</sup> T-cell activator via the sigma-1 receptor to enhance HIV-1 infection

30 A SYSTEMATIC REVIEW ON THE INFLUENCE OF HLA-B POLYMORPHISMS ON HIV-1 MOTHER-TO-CHILD-TRANSMISSION.

31 Perinatal HIV-1 transmission: Fc gamma receptor variability associates with maternal infectiousness and infant susceptibility.

32 Association of HIV-1 Envelope-Specific Breast Milk IgA Responses with Reduced Risk of Postnatal Mother-to-Child Transmission of HIV-1.

33 Epidemiology of HIV-1 infection in agricultural plantation residents in Kericho, Kenya: preparation for vaccine feasibility studies.

34 Targeting HIV-1 Protease Autoprocessing for High-throughput Drug Discovery and Drug Resistance Assessment

35 Discovery of piperidine-substituted thiazolo[5,4-d]pyrimidine derivatives as potent and orally bioavailable HIV-1 non-nucleoside reverse transcriptase inhibitors

36 Identification of a large, fast-expanding HIV-1 subtype B transmission cluster among MSM in Valencia, Spain.

37 Insight into analysis of interactions of saquinavir with HIV-1 protease in comparison between the wild-type and G48V and G48V/L90M mutants based on QM and QM/MM calculations.

38 Association of circulatory Tfh-like cells with neutralizing antibody responses among chronic HIV-1 subtype C infected long-term nonprogressors and progressors.

39 Structural Insights into the Mechanisms of Action of Short-Peptide HIV-1 Fusion Inhibitors Targeting the Gp41 Pocket

40 Molecular characteristic of HIV-1 CRF01_AE in Nanjing from 2015 to 2017.

41 Design and Biological Evaluation of m-Xylene Thioether-stapled Short Helical Peptides Targeting the HIV-1 gp41 Hexameric Coiled-Coil Fusion Complex.

42 Correction: Conformational states of HIV-1 reverse transcriptase for nucleotide incorporation vs pyrophosphorolysis - Binding of Foscarnet (ACS Chemical Biology (2016) 11: 8 (2158-2164) DOI: 10.1021/acschembio.6b00187)

43 Use of Dried Blood Spots to Elucidate Full-Length Transmitted/Founder HIV-1 Genomes

44 Transmission dynamics of HIV-1 subtype B strains in Indonesia.

45 Effectiveness, safety/tolerability of OBV/PTV/r ± DSV in patients with HCV genotype 1 or 4 with/without HIV-1 co-infection, chronic kidney disease (CKD) stage IIIb-V and dialysis in Spanish clinical practice - Vie-KinD study.

46 Contribution of the Microbiota to Intestinal Homeostasis and its Role in the Pathogenesis of HIV-1 Infection.

47 Enzymatic Glycosylation of Triazole-Linked GlcNAc/Glc-Peptides: Synthesis, Stability and Anti-HIV Activity of Triazole-Linked HIV-1 gp41 Glycopeptide C34 Analogues

48 Large transmission clusters of HIV-1 main genotypes among HIV-1 individuals before antiretroviral therapy in the Hebei province, China.

49 Treatment Adherence And Persistence Among HIV-1 Patients Newly Starting Treatment.

50 Computational design, synthesis and evaluation of new sulphonamide derivatives targeting HIV-1 gp120.

51 Performance of an Alternative Laboratory-Based HIV Diagnostic Testing Algorithm Using HIV-1 RNA Viral Load.

52 Prevalence of HIV-1 drug resistance amongst newly diagnosed HIV-infected infants age 4–8 weeks, enrolled in three nationally representative PMTCT effectiveness surveys, South Africa: 2010, 2011–12 and 2012–13

53 Evolving understanding of HIV-1 reverse transcriptase structure, function, inhibition, and resistance.

54 Epidemiology of transmitted drug resistance mutations in an HIV-1 subtype C high-prevalence setting and impact on 1-year virological failure

55 Stability behaviour of antiretroviral drugs and their combinations. 11: Characterization of interaction products of zidovudine and efavirenz, and evaluation of their anti HIV-1 activity, and physiochemical and ADMET properties

56 Proton transfer and drug binding details revealed in neutron diffraction studies of wild-type and drug resistant HIV-1 protease

57 Following the path: Increasing trends of HIV-1 drug resistance in China

58 Trend of HIV-1 drug resistance in China: A systematic review and meta-analysis of data accumulated over 17 years (2001–2017)

59 (Q)SAR Models of HIV-1 protein inhibition by drug-like compounds

60 Perspectives on the Barrier to Resistance for Dolutegravir + Lamivudine, a Two-Drug Antiretroviral Therapy for HIV-1 Infection

61 Integrase strand transfer inhibitor (INSTI)-resistance mutations for the surveillance of transmitted HIV-1 drug resistance

62 Semen Extracellular Vesicles From HIV-1-Infected Individuals Inhibit HIV-1 Replication In Vitro, and Extracellular Vesicles Carry Antiretroviral Drugs In Vivo

63 Forecasting Prevalence of HIV-1 Integrase Strand Transfer Inhibitor (INSTI) Drug Resistance: A Modeling Study

64 Magnetically guided non-invasive CRISPR-Cas9/gRNA delivery across blood-brain barrier to eradicate latent HIV-1 infection.

65 Discovery of dihydroxyindole-2-carboxylic acid derivatives as dual allosteric HIV-1 Integrase and Reverse Transcriptase associated Ribonuclease H inhibitors.

66 Chromenone derivatives as a versatile scaffold with dual mode of inhibition of HIV-1 reverse transcriptase-associated Ribonuclease H function and integrase activity.

67 Mathematical analysis of an age-structured HIV-1 infection model with CTL immune response.

68 Contrasting roles for TLR ligands in HIV-1 pathogenesis.

69 Rilpivirine in HIV-1-positive women initiating pregnancy: to switch or not to switch?

70 2-(Arylamino)-6-(trifluoromethyl)nicotinic Acid Derivatives: New HIV-1 RT Dual Inhibitors Active on Viral Replication.

71 Remodeling of the core leads HIV-1 pre-integration complex in the nucleus of human lymphocytes.

72 Compartmentalization and clonal amplification of HIV-1 in the male genital tract characterized using next generation sequencing.

73 Characterisation of HIV-1 Molecular Epidemiology in Nigeria: Origin, Diversity, Demography and Geographic Spread

74 Molecular epidemiology of the HIV-1 subtype B sub-epidemic in Bulgaria

75 Cloaked similarity between HIV-1 and SARS-CoV suggests an anti-SARS strategy

76 Engineering and Validation of a Vector for Concomitant Expression of Rare Transfer RNA (tRNA) and HIV-1 nef Genes in Escherichia coli.

77 The clinical and parasitological presentation of Plasmodium falciparum malaria in Uganda is unaffected by HIV-1 infection

78 Immunological effects of HIV-1 infection on the humoral response to malaria in an African population

79 Vertical transmission of HIV-1 infection

80 Mortality in Patients with HIV-1 Infection Starting Antiretroviral Therapy in South Africa, Europe, or North America: A Collaborative Analysis of Prospective Studies

81 Increasing rates of malarial fever with deteriorating immune status in HIV-1-infected Ugandan adults

82 Effect of HIV-1 and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Uganda: a cohort study

83 Switch from Ritonavir to Indinavir in Combination Therapy for HIV-1—Infected Children

84 The influence of HIV-1 exposure and infection on levels of passively acquired antibodies to measles virus in Zambian infants

85 The Influence of HIV-1 Exposure and Infection on Levels of Passively Acquired Antibodies to Measles Virus in Zambian Infants

86 Mortality in patients with HIV-1 infection starting antiretroviral therapy in South Africa, Europe, or North America: a collaborative analysis of prospective studies

87 Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda

88 Frequent recovery of HIV-1 from genital herpes simplex virus lesions in HIV-1-infected men

89 in silico sar studies of hiv-1 inhibitors

90 molecular epidemiology of hiv-1 infection among men who have sex with men in taiwan from 2013 to 2015.

91 intra-ventral tegmental hiv-1 tat1-86 attenuates nicotine-mediated locomotor sensitization and alters mesocorticolimbic erk and creb signaling in rats

92 lessons learned in developing a commercial fiv vaccine: the immunity required for an effective hiv-1 vaccine

93 pathophysiology of cd4+ t-cell depletion in hiv-1 and hiv-2 infections

94 unexpected mutations in hiv-1 that confer resistance to the tat inhibitor didehydro-cortistatin a

95 persistently hiv-1 seronegative nairobi sex workers are susceptible to in vitro infection

96 elevated level of cd4+ t cell immune activation in acutely hiv-1-infected stage associates with increased il-2 production and cycling expression, and subsequent cd4+ t cell preservation

97 inhibition of hiv-1 gene expression by ciclopirox and deferiprone, drugs that prevent hypusination of eukaryotic initiation factor 5a

98 microfluidic chip-based nucleic acid testing using gingival crevicular fluid as a new technique for detecting hiv-1 infection

99 hologram quantitative structure–activity relationship and comparative molecular field analysis studies within a series of tricyclic phthalimide hiv-1 integrase inhibitors

100 correction to: a ccr5+ memory subset within hiv-1-infected primary resting cd4+ t cells is permissive for replication-competent, latently infected viruses in vitro

101 impact of hmgb1/tlr ligand complexes on hiv-1 replication: possible role for flagellin during hiv-1 infection

Keyword Connections

Journals

Research Groups

Bibliographies